The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Artificial Intelligence in Drug Discovery Market Research Report 2024

Global Artificial Intelligence in Drug Discovery Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1736923

No of Pages : 105

Ask Your Query

Synopsis

Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.

The global Artificial Intelligence in Drug Discovery market was valued at US$ 1366 million in 2023 and is anticipated to reach US$ 8908 million by 2030, witnessing a CAGR of 30.7% during the forecast period 2024-2030.

The key manufacturers of Artificial Intelligence in Drug Discovery include IBM, Google (Alphabet), Atomwise, Schrodinger, Microsoft, etc. The top five players have a combined market share of about 19%.

North America is the world's largest market, accounting for about 46%. It is followed by Europe and Asia, each with about 25%. The Asian market is slowly expanding.

The application of Artificial Intelligence in Drug Discovery mainly includes hardware, software and service. Hardware is by far the most widely used, with a market share of about 53%. The market share of software types is expected to increase further.
Early drug discovery, preclinical phase, clinical phase, and regulatory approval are the main application stages. The current preclinical market share is about 38%, and it is expected to be more widely used in the preclinical stage in the future.

This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Drug Discovery.

Report Scope

The Artificial Intelligence in Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence in Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Artificial Intelligence in Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • IBM
  • Exscientia
  • Google(Alphabet)
  • Microsoft
  • Atomwise
  • Schrodinger
  • Aitia
  • Insilico Medicine
  • NVIDIA
  • XtalPi
  • BPGbio
  • Owkin
  • CytoReason
  • Deep Genomics
  • Cloud Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Verge Genomics
  • Valo Health
  • Envisagenics
  • Euretos
  • BioAge Labs
  • Iktos
  • BioSymetrics
  • Evaxion Biotech
  • Aria Pharmaceuticals, Inc

Segment by Type

  • Hardware
  • Software
  • Service

Segment by Application

  • Early Drug Discovery
  • Preclinical Phase
  • Clinical Phase
  • Regulatory Approval

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Early Drug Discovery
1.3.3 Preclinical Phase
1.3.4 Clinical Phase
1.3.5 Regulatory Approval
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2019-2030)
2.2 Artificial Intelligence in Drug Discovery Growth Trends by Region
2.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence in Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence in Drug Discovery Market Dynamics
2.3.1 Artificial Intelligence in Drug Discovery Industry Trends
2.3.2 Artificial Intelligence in Drug Discovery Market Drivers
2.3.3 Artificial Intelligence in Drug Discovery Market Challenges
2.3.4 Artificial Intelligence in Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue
3.1.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence in Drug Discovery Revenue
3.4 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery Revenue in 2023
3.5 Artificial Intelligence in Drug Discovery Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence in Drug Discovery Product Solution and Service
3.7 Date of Enter into Artificial Intelligence in Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Drug Discovery Breakdown Data by Type
4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence in Drug Discovery Breakdown Data by Application
5.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence in Drug Discovery Market Size (2019-2030)
6.2 North America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Drug Discovery Market Size (2019-2030)
7.2 Europe Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence in Drug Discovery Market Size (2019-2030)
9.2 Latin America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence in Drug Discovery Introduction
11.1.4 IBM Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.1.5 IBM Recent Development
11.2 Exscientia
11.2.1 Exscientia Company Detail
11.2.2 Exscientia Business Overview
11.2.3 Exscientia Artificial Intelligence in Drug Discovery Introduction
11.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.2.5 Exscientia Recent Development
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Detail
11.3.2 Google(Alphabet) Business Overview
11.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Introduction
11.3.4 Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.3.5 Google(Alphabet) Recent Development
11.4 Microsoft
11.4.1 Microsoft Company Detail
11.4.2 Microsoft Business Overview
11.4.3 Microsoft Artificial Intelligence in Drug Discovery Introduction
11.4.4 Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.4.5 Microsoft Recent Development
11.5 Atomwise
11.5.1 Atomwise Company Detail
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence in Drug Discovery Introduction
11.5.4 Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.5.5 Atomwise Recent Development
11.6 Schrodinger
11.6.1 Schrodinger Company Detail
11.6.2 Schrodinger Business Overview
11.6.3 Schrodinger Artificial Intelligence in Drug Discovery Introduction
11.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.6.5 Schrodinger Recent Development
11.7 Aitia
11.7.1 Aitia Company Detail
11.7.2 Aitia Business Overview
11.7.3 Aitia Artificial Intelligence in Drug Discovery Introduction
11.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.7.5 Aitia Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Detail
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.8.5 Insilico Medicine Recent Development
11.9 NVIDIA
11.9.1 NVIDIA Company Detail
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA Artificial Intelligence in Drug Discovery Introduction
11.9.4 NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.9.5 NVIDIA Recent Development
11.10 XtalPi
11.10.1 XtalPi Company Detail
11.10.2 XtalPi Business Overview
11.10.3 XtalPi Artificial Intelligence in Drug Discovery Introduction
11.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.10.5 XtalPi Recent Development
11.11 BPGbio
11.11.1 BPGbio Company Detail
11.11.2 BPGbio Business Overview
11.11.3 BPGbio Artificial Intelligence in Drug Discovery Introduction
11.11.4 BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.11.5 BPGbio Recent Development
11.12 Owkin
11.12.1 Owkin Company Detail
11.12.2 Owkin Business Overview
11.12.3 Owkin Artificial Intelligence in Drug Discovery Introduction
11.12.4 Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.12.5 Owkin Recent Development
11.13 CytoReason
11.13.1 CytoReason Company Detail
11.13.2 CytoReason Business Overview
11.13.3 CytoReason Artificial Intelligence in Drug Discovery Introduction
11.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.13.5 CytoReason Recent Development
11.14 Deep Genomics
11.14.1 Deep Genomics Company Detail
11.14.2 Deep Genomics Business Overview
11.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Introduction
11.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.14.5 Deep Genomics Recent Development
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Detail
11.15.2 Cloud Pharmaceuticals Business Overview
11.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Introduction
11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.15.5 Cloud Pharmaceuticals Recent Development
11.16 BenevolentAI
11.16.1 BenevolentAI Company Detail
11.16.2 BenevolentAI Business Overview
11.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Introduction
11.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.16.5 BenevolentAI Recent Development
11.17 Cyclica
11.17.1 Cyclica Company Detail
11.17.2 Cyclica Business Overview
11.17.3 Cyclica Artificial Intelligence in Drug Discovery Introduction
11.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.17.5 Cyclica Recent Development
11.18 Verge Genomics
11.18.1 Verge Genomics Company Detail
11.18.2 Verge Genomics Business Overview
11.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Introduction
11.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.18.5 Verge Genomics Recent Development
11.19 Valo Health
11.19.1 Valo Health Company Detail
11.19.2 Valo Health Business Overview
11.19.3 Valo Health Artificial Intelligence in Drug Discovery Introduction
11.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.19.5 Valo Health Recent Development
11.20 Envisagenics
11.20.1 Envisagenics Company Detail
11.20.2 Envisagenics Business Overview
11.20.3 Envisagenics Artificial Intelligence in Drug Discovery Introduction
11.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.20.5 Envisagenics Recent Development
11.21 Euretos
11.21.1 Euretos Company Detail
11.21.2 Euretos Business Overview
11.21.3 Euretos Artificial Intelligence in Drug Discovery Introduction
11.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.21.5 Euretos Recent Development
11.22 BioAge Labs
11.22.1 BioAge Labs Company Detail
11.22.2 BioAge Labs Business Overview
11.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Introduction
11.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.22.5 BioAge Labs Recent Development
11.23 Iktos
11.23.1 Iktos Company Detail
11.23.2 Iktos Business Overview
11.23.3 Iktos Artificial Intelligence in Drug Discovery Introduction
11.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.23.5 Iktos Recent Development
11.24 BioSymetrics
11.24.1 BioSymetrics Company Detail
11.24.2 BioSymetrics Business Overview
11.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Introduction
11.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.24.5 BioSymetrics Recent Development
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Detail
11.25.2 Evaxion Biotech Business Overview
11.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Introduction
11.25.4 Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.25.5 Evaxion Biotech Recent Development
11.26 Aria Pharmaceuticals, Inc
11.26.1 Aria Pharmaceuticals, Inc Company Detail
11.26.2 Aria Pharmaceuticals, Inc Business Overview
11.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Introduction
11.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.26.5 Aria Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock